Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RPRD Diagnostics provides comprehensive and customizable clinical pharmacogenomics (PGx) testing using next generation sequencing and microarray platforms. Flagship WPS® platform covers nearly 1,200 PGx genes and over 4,600 markers. Clinical evidence supports utility in pain management, cardiology, psychiatry, and adverse drug reaction mitigation. Broad implementation in diverse patient populations and collaborations with major academic centers support clinical validity and utility.[1][3][4][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RPRD Diagnostics.